2-Phenyl-3,6-dimethylmorpholine is a drug with
stimulant and
anorectic
An anorectic or anorexic is a drug which reduces appetite, resulting in lower food consumption, leading to weight loss. By contrast, an appetite stimulant is referred to as orexigenic.
The term is (from the Greek ''ἀν-'' (an-) = "without" a ...
effects, related to
phenmetrazine
Phenmetrazine ( INN, USAN, BAN) (brand name Preludin, and many others) is a stimulant drug first synthesized in 1952 and originally used as an appetite suppressant, but withdrawn from the market in the 1980s due to widespread abuse. It was initi ...
.
Based on what is known from other phenylmorpholines with similar structure, it likely acts as a
serotonin reuptake inhibitor
A serotonin reuptake inhibitor (SRI) is a type of drug which acts as a reuptake inhibitor of the neurotransmitter serotonin (5-hydroxytryptamine, or 5-HT) by blocking the action of the serotonin transporter (SERT). This in turn leads to incre ...
and may produce
antidepressant-like effects. Anecdotal reports suggest, however, that the compound is inactive aside from anorectic effects.
See also
*
3-Fluorophenmetrazine
3-Fluorophenmetrazine (also known as 3-FPM, 3-FPH and PAL-593) is a phenylmorpholine-based stimulant and fluorinated analogue of phenmetrazine that has been sold online as a designer drug.
Chemistry
3-Fluorophenmetrazine is a fluorinated anal ...
*
G-130
G-130 (GP-130, 2-Phenyl-5,5-dimethyltetrahydro-1,4-oxazine) is a drug with stimulant and anorectic effects, related to phenmetrazine.
Structural analogs
Compounds related to G-130 and radafaxine were synthesized that behave as combined inhi ...
(2-Phenyl-5,5-dimethylmorpholine)
* 3,4-
Phendimetrazine
Phendimetrazine (Bontril, Adipost, Anorex-SR, Appecon, Melfiat, Obezine, Phendiet, Plegine, Prelu-2, Statobex) is a stimulant drug of the morpholine chemical class used as an appetite suppressant.
Pharmacology
Phendimetrazine functions as a p ...
(2-Phenyl-3,4-dimethylmorpholine)
*
PDM-35 (3,5-Phendimetrazine) (2-Phenyl-3,5-dimethylmorpholine)
*
Manifaxine
Manifaxine (developmental code name GW-320,659) is a norepinephrine–dopamine reuptake inhibitor developed by GlaxoSmithKline through structural modification of radafaxine, an isomer of hydroxybupropion and one of the active metabolites of bup ...
*
Radafaxine
References
Stimulants
Substituted amphetamines
Phenylmorpholines
Designer drugs
Phenyl compounds
{{nervous-system-drug-stub